These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23242436)

  • 1. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system.
    von der Thüsen JH; Tham YS; Pattenden H; Rice A; Dusmet M; Lim E; Nicholson AG
    J Thorac Oncol; 2013 Jan; 8(1):37-44. PubMed ID: 23242436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance and grading of stromal invasion in pT1 adenocarcinoma of lung].
    Xu Y; Zhou XJ; Dong YC; Ma HH; Lu ZF; He Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):451-5. PubMed ID: 19781191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung.
    Xu L; Tavora F; Burke A
    Am J Surg Pathol; 2013 Jul; 37(7):1100-8. PubMed ID: 23681071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size.
    Takahashi Y; Ishii G; Aokage K; Hishida T; Yoshida J; Nagai K
    Lung Cancer; 2013 Feb; 79(2):118-24. PubMed ID: 23177278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].
    Ding FG; Liu B; Zhang XH; Xu Y; Yu B; Zhang RS; He Y; Ma HH; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):145-50. PubMed ID: 22800475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.
    Zombori T; Furák J; Nyári T; Cserni G; Tiszlavicz L
    J Clin Pathol; 2018 Feb; 71(2):135-140. PubMed ID: 28747392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
    Harada M; Hato T; Horio H
    J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
    Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
    Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis.
    Haruki T; Shomori K; Shiomi T; Taniguchi Y; Nakamura H; Ito H
    Eur J Cardiothorac Surg; 2011 May; 39(5):763-8. PubMed ID: 20864350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
    Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
    Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
    Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
    Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
    Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Pääkkö P; Lappi-Blanco E; Kaarteenaho R
    Histopathology; 2017 Sep; 71(3):425-436. PubMed ID: 28401582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.